World's Best Scientists 2026 revealed!
Matthew J. Maurer

Matthew J. Maurer

D-Index & Metrics

Medicine

D-Index
91
Citations
37542
World Ranking
11603
National Ranking
5954

Overview

Matthew J. Maurer is affiliated with the Mayo Clinic in the United States and has a primary focus on medicine, contributing extensively across various subfields including pathology and forensic medicine, molecular biology, cardiology and cardiovascular medicine, oncology, and genetics.

The areas of research that define Maurer's career involve lymphoma diagnosis and treatment, amyloidosis with an emphasis on diagnosis, treatment, and outcomes, parathyroid disorders and treatments, chronic lymphocytic leukemia research, cardiomyopathy and myosin studies, CAR-T cell therapy research, and cardiovascular function and risk factors.

They have published in a variety of prominent scientific venues, with frequent contributions to:

  • Blood
  • Journal of the American College of Cardiology
  • Circulation
  • Journal of Cardiac Failure
  • Hematological Oncology

Some recent papers associated with Matthew J. Maurer's field of interest include:

  • "Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial", 2020, The Lancet
  • "Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases", 2021, European Heart Journal
  • "2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis", 2023, Journal of the American College of Cardiology
  • "Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases", 2021, European Journal of Heart Failure
  • "ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging", 2021, Circulation Cardiovascular Imaging

Matthew J. Maurer has collaborated regularly with several frequently co-authoring scientists including:

  • James R. Cerhan
  • Thomas M. Habermann
  • Brian K. Link
  • Grzegorz S. Nowakowski
  • Yucai Wang

This body of work reflects a broad and interdisciplinary engagement with medical research, particularly in the overlap between cardiovascular medicine and hematologic malignancies. Their contributions span diagnostic, therapeutic, and consensus guideline approaches contributing to contemporary medical knowledge within multiple overlapping domains of medicine.

Best Publications

  • Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

    Mathew S. Maurer;Jeffrey H. Schwartz;Balarama Gundapaneni;Perry M. Elliott

  • Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

    Julian D. Gillmore;Mathew S. Maurer;Rodney H. Falk;Giampaolo Merlini

  • Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

    Michael Crump;Sattva S. Neelapu;Umar Farooq;Eric Van Den Neste

  • Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    Iacopo Olivotto;Artur Oreziak;Roberto Barriales-Villa;Theodore P. Abraham

  • Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

    Evanthia Galanis;Jan C. Buckner;Matthew J. Maurer;Jeffrey I. Kreisberg

  • Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

    Carla Casulo;Michelle Byrtek;Keith L. Dawson;Xiaolei Zhou

  • Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

    Pablo Garcia-Pavia;Claudio Rapezzi;Yehuda Adler;Michael Arad

  • ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging

    Sharmila Dorbala;Yukio Ando;Sabahat Bokhari;Angela Dispenzieri

  • Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

    Lao H. Saal;Peter Johansson;Karolina Holm;Sofia K. Gruvberger-Saal

  • ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

    Edgardo R. Parrilla Castellar;Elaine S. Jaffe;Jonathan W. Said;Steven H. Swerdlow

  • Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis

    Mathew S. Maurer;Perry Elliott;Raymond Comenzo;Marc Semigran

  • Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

    Evanthia Galanis;Kurt A. Jaeckle;Matthew J. Maurer;Joel M. Reid

  • Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

    Matthew J. Maurer;Hervé Ghesquières;Hervé Ghesquières;Jean Philippe Jais;Thomas E. Witzig

  • Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.

    Adam Castano;Muhammad Haq;David L. Narotsky;Jeff Goldsmith

  • Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource

    Brian K. Link;Matthew J. Maurer;Grzegorz S. Nowakowski;Stephen M. Ansell

  • Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303

    Nancy L. Bartlett;Wyndham H. Wilson;Sin Ho Jung;Eric D. Hsi

  • Multimorbidity in Older Adults With Cardiovascular Disease

    Daniel E. Forman;Mathew S. Maurer;Cynthia Boyd;Ralph Brindis

  • Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).

    Frederick L. Ruberg;Mathew S. Maurer;Daniel P. Judge;Steven Zeldenrust

  • ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/ SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis part 2 of 2-diagnostic criteria and appropriate utilization

    Sharmila Dorbala;Yukio Ando;Sabahat Bokhari;Angela Dispenzieri

  • Diastolic heart failure.

    Mathew S Maurer;Milton Packer;Daniel Burkhoff

Frequent Co-Authors

James R. Cerhan
James R. Cerhan Mayo Clinic
Thomas E. Witzig
Thomas E. Witzig Mayo Clinic
Susan L. Slager
Susan L. Slager Mayo Clinic
Anne J. Novak
Anne J. Novak Mayo Clinic
David J. Inwards
David J. Inwards Mayo Clinic
Ahmet Dogan
Ahmet Dogan Memorial Sloan Kettering Cancer Center
George J. Weiner
George J. Weiner University of Iowa
Ann L. Oberg
Ann L. Oberg Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA is just one way to start a rewarding healthcare career. Today’s students have many alternative and online pathways to prepare for roles in healthcare and related fields. For example, those interested in nursing can consider schools that help you become an lpn school without teas test requirements, making entry into the profession more accessible.

If you are interested in healthcare leadership, consider enrolling in an accelerated healthcare administration degree online. This allows you to fast-track your education and move into administrative or management roles sooner.

Registered Nurses seeking career advancement can find specialized rn to fnp bridge programs that help bridge the gap between clinical nursing and advanced practice roles, such as Family Nurse Practitioner.

For those passionate about wellness and preventive care, pursuing one of the best online nutrition programs provides the knowledge to support healthier communities. These flexible online options give aspiring healthcare professionals a variety of career starting points beyond the traditional medical school route.

Best Scientists Citing Matthew J. Maurer

Trending Scientists